Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy
MONDAY, Nov. 27, 2023 -- For people using testosterone as gender-affirming hormone therapy (GAHT), mean hematocrit varies from 41.84 to 45.68 percent, which is within the normal range, according to a study published online Nov. 27 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2023 Category: Pharmaceuticals Source Type: news
Cumulative incidence of all-cause knee injury, concussion, and stress fracture among transgender patients on gender-affirming hormone therapy: an exploratory retrospective cohort study - Miro EW, Taylor E, Curtin A, Newman MG, Ose D, Knox J.
Previous research has shown a discrepancy in incidences of knee injuries, stress fractures, and concussions between cisgender men and women. Little is known regarding the incidence of musculoskeletal injuries among patients on gender-affirming hormone ther... (Source: SafetyLit)
Source: SafetyLit - November 27, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Improving Shared Decision-Making in HER2-Low Breast Cancer Improving Shared Decision-Making in HER2-Low Breast Cancer
A breast cancer specialist and a patient with metastatic HER2-low disease share perspectives on optimizing doctor-patient communication at key changes in treatment, such as starting hormonal therapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2023 Category: Consumer Health News Tags: None Care Cues Source Type: news
Vatican says transgender people can be baptized
Create your free profile or log in to save this article Create your free profile or log in to save this article Vatican officials said Wednesday that transgender people can be baptized in the Catholic church. “A transgender person, even if they have undergone hormone therapy and sex-reassignment…#vatican #catholic #italian #bishopjosenegri #amaro #brazil #catholics #jamesmartin (Source: Reuters: Health)
Source: Reuters: Health - November 8, 2023 Category: Consumer Health News Source Type: news
Oral Contraceptives May Protect Against Rheumatoid Arthritis
WEDNESDAY, Nov. 8, 2023 -- Oral contraceptive use appears to protect against rheumatoid arthritis (RA), while menopausal hormone therapy (MHT) use may increase the risk for late-onset RA, according to a study published online Sept. 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 8, 2023 Category: Pharmaceuticals Source Type: news
Breakthrough 4p-a-day pill HALVES risk of getting breast cancer: Up to 300,000 at-risk women will be offered anastrozole on NHS in 'new era' of treatment that will save THOUSANDS of lives
The NHS will offer the hormone therapy anastrozole to 289,000 women deemed to be at moderate or high risk of breast cancer which could halve their risk of developing the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2023 Category: Consumer Health News Source Type: news
Hundreds of thousands of woman will be offered daily pill that will HALVE their risk of developing breast cancer
The NHS will offer the hormone therapy anastrozole to 289,000 women deemed to be at moderate or high risk of breast cancer which could halve their risk of developing the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2023 Category: Consumer Health News Source Type: news
Menopausal Hormone Therapy Less Prescribed for Black Women Menopausal Hormone Therapy Less Prescribed for Black Women
"Gaps in treatment can be used to inform healthcare providers about menopausal HT prescribing disparities, with the goal of improving equitable and advanced patient care among disadvantaged populations."MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 3, 2023 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
How AI Can Make Cancer Treatment More Equitable
Many are aware of the Cancer Moonshot—an ambitious and hopeful initiative of the U.S. government to reduce cancer-related death rates by 50% by the year 2047. It will take an army to achieve this goal, composed of the brightest minds and biggest hearts in healthcare, science, and technology. Many parties will be involved—the federal government, healthcare providers, researchers, patients, caregivers, and advocates, among others in both the public and private sectors. One of the most pivotal tools that can help propel us toward this lofty goal is artificial intelligence (AI), which is poised to revolutionize can...
Source: TIME: Health - October 18, 2023 Category: Consumer Health News Authors: Andre Esteva Tags: Uncategorized Innovation Source Type: news
World Menopause Day – Information Resources for Perimenopause and Menopause
About Perimenopause and Menopause
Perimenopause, sometimes referred to as the menopausal transition, is a phase in a life characterized by the natural progression toward menopause when menstruation or periods stop permanently. The onset of perimenopause varies, with some people noticing the first signs of this transition in their 40s, while others may experience changes as early as their mid-30s.
During perimenopause, estrogen levels fluctuate irregularly. This hormonal fluctuation can lead to changes in menstrual patterns, including longer or shorter cycles and instances where the ovaries do not release an egg (ovulati...
Source: The Cornflower - October 18, 2023 Category: Databases & Libraries Authors: Bobbi Newman Tags: Public Libraries Resource Sharing health information menopause perimenopause world menopause day Source Type: news
Hormone Therapy Less Effective in Women With Obesity Hormone Therapy Less Effective in Women With Obesity
Women with obesity experience greater menopausal symptoms but substantially less relief from hormone therapy than women without obesity, according to a study.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - October 5, 2023 Category: Endocrinology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Menopausal Hormone Therapy Less Prescribed for Black Women Menopausal Hormone Therapy Less Prescribed for Black Women
The prescribing, counseling, and use of hormone therapy to treat menopausal symptoms is substantially more common among white women than among Black women, according to a literature review.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - October 3, 2023 Category: Endocrinology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Menopausal Women With Obesity Endure Worse Symptoms, Less HT Relief
(MedPage Today) -- PHILADELPHIA -- Women with obesity may experience worse menopausal symptoms and see less relief from hormone therapy (HT), according to a pilot study.
When compared with women without obesity, those with a BMI of 30 or greater... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 2, 2023 Category: Cardiology Source Type: news
Fezolinetant Benefits Women Not Suited for Hormone Therapy
(MedPage Today) -- PHILADELPHIA -- Fezolinetant (Veozah) improved menopause-related vasomotor symptoms in women unsuited or unwilling to take hormone therapy, according to a pooled analysis of two phase III studies.
The analysis of the SKYLIGHT... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 30, 2023 Category: Endocrinology Source Type: news
Age, Race, Education Most Prevalent Disparities Tied to Menopausal Hormone Therapy Rx
WEDNESDAY, Sept. 27, 2023 -- Age, race, and education are the most prevalent disparities associated with menopausal hormone therapy (MHT) prescribing, according to research presented at the annual meeting of the North American Menopause Society,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 27, 2023 Category: Pharmaceuticals Source Type: news
